Both in Biotechnology
REGENXBIO vs 4D Molecular Therapeutics
Over the past year RGNX returned −33.3% and FDMT returned +14.2%; their daily moves had a correlation of 0.44.
RGNX −33.3% FDMT +14.2%Growth of $1, one year, split-adjusted
| Metric | RGNX | FDMT |
|---|---|---|
| Price | $7.71 | $12.28 |
| Market cap | $509.0M | $678.4M |
| Today | +1.05% | +2.76% |
| 1 month | +3.5% | −2.2% |
| 6 months | −24.6% | +17.9% |
| Year to date | −46.5% | +63.7% |
| 1 year | −35.7% | +9.4% |
| Revenue growth (YoY) | +405.7% | +25106.7% |
| Gross margin | 99.0% | 100.0% |
| Net margin | 21.0% | −1929.0% |
| P/E (TTM) | — | — |
| Price / sales | 2.9× | 7.4× |
| Net cash | $105.5M | $341.7M |
| Dividend yield | — | — |
| Volatility (60d) | 87.0% | 76.2% |
| Short % of float | 19.4% | 21.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).